Praxis Precision Medicines, Inc. Announces Pricing of $200

BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating...

Related Keywords

Boston ,Massachusetts ,United States ,New York ,Piper Sandler ,Praxis Precision Medicines Inc ,Exchange Commission ,Needham Company ,Nasdaq ,Hc Wainwright Co ,Truist Securities Inc ,Guggenheim Securities ,Prospectus Department ,Piper Sandler Co ,Equity Syndicate Department ,Precision Medicines ,Truist Securities ,Private Securities Litigation Reform Act ,Praxi Annual Report ,